Mazaticol

DB13448

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 405.57
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

552 Data
Aclidinium The risk or severity of adverse effects can be increased when Mazaticol is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Mazaticol.
Mirabegron The risk or severity of urinary retention can be increased when Mazaticol is combined with Mirabegron.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Mazaticol.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Mazaticol.
Tiotropium The risk or severity of adverse effects can be increased when Mazaticol is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Mazaticol is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Mazaticol is combined with Umeclidinium.
Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Mazaticol.
Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Mazaticol.
Metoclopramide The therapeutic efficacy of Mazaticol can be decreased when used in combination with Metoclopramide.
Glycopyrronium The risk or severity of adverse effects can be increased when Mazaticol is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Mazaticol is combined with Botulinum toxin type A.
Glucagon Mazaticol may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Mazaticol may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Mazaticol is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Mazaticol is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Mazaticol is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Mazaticol is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Mazaticol is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Mazaticol is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Mazaticol is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Mazaticol is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Mazaticol is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Mazaticol is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Mazaticol is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Mazaticol is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Mazaticol is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Mazaticol is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Mazaticol is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Mazaticol is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Mazaticol is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Mazaticol is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Mazaticol is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Mazaticol is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Mazaticol is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Mazaticol is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Mazaticol is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Mazaticol is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Mazaticol is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Mazaticol is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Mazaticol is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Mazaticol is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Mazaticol is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Mazaticol is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Mazaticol is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Mazaticol is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Mazaticol is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Mazaticol is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Mazaticol is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Mazaticol is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Mazaticol is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Mazaticol is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Mazaticol is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Mazaticol is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Mazaticol is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Mazaticol is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Mazaticol is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Mazaticol is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Mazaticol is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Mazaticol.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mazaticol.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Mazaticol.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Mazaticol.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Mazaticol.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Mazaticol.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Mazaticol.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Mazaticol.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Mazaticol.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Mazaticol.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mazaticol.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Mazaticol.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Mazaticol.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Mazaticol.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Mazaticol.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Mazaticol.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Mazaticol.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Mazaticol.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Mazaticol.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Mazaticol.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Mazaticol.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Mazaticol.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Mazaticol.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Mazaticol.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Mazaticol.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Mazaticol.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Mazaticol.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Mazaticol.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Mazaticol.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Mazaticol.
Tolterodine The risk or severity of adverse effects can be increased when Tolterodine is combined with Mazaticol.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul